Clinical Trial Type: Myelofibrosis

Name of Trial:  Karyopharm XPORT-MF-034 What type of Cancer is this for?  Myelofibrosis (Blood cancer) Phase: 3 Who is this trial for? Patients with myelofibrosis or post-essential thrombocythemia (ET) or postpolycythemia-vera (PV) myelofibrosis. What biomarkers involved?  None What is the National Clinical Trial #? NCT04562389 Brief Summary: Purpose of this study is to evaluate the